March 8, 2012
The Food and Drug Administration (FDA) has issued a warning concerning a counterfeit cancer drug that may be in some hospitals. According to a recent press release from the agency, 19 medical practices in the United States have received warning letters after purchasing the counterfeit versions of the cancer drug, Avastin, through foreign sources. The agency says that other facilities may have purchased the fake medications as well.
The FDA says that the counterfeit drugs are labeled Avastin, manufactured by Roche. Roche manufactures the drug outside the United States and is the sister company of Genentech, Inc., which manufactures it in the United States.
It was determined through testing that certain batches of the Roche version of Avastin didn’t contain the active ingredient bevacizumab, which means patients who took the counterfeit medications may not have received the treatments they needed.
Packages or vials may be counterfeit if they are:
- labeled with Roche as the manufacturer,
- or display batch numbers that start with B6010, B6011, or B86017.
The counterfeit drugs came from Quality Specialty Products (QSP), a foreign supplier that’s also known as Montana Health Care Solutions. Volunteer Distribution in Gainesboro, Tennessee is a distributor of QSP’s products. The FDA asks that medical staff with products from these suppliers contact them immediately.